(Q35595706)

9 August 2017

Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules (English)

1 reference

9 August 2017

Jack F Fowler

1

1 reference

9 August 2017

Paul M Harari

series ordinal

2

1 reference

9 August 2017

Felix Leborgne

series ordinal

3

1 reference

9 August 2017

José H Leborgne

series ordinal

4

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Radiotherapy and Oncology

9 August 2017

1 reference

9 August 2017

69

1 reference

9 August 2017

2

1 reference

9 August 2017

161-168

1 reference

Altered fractionation trials in head and neck cancer

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

From CHART to CHARTWEL in Non-small Cell Lung Cancer: Clinical Radiobiological Modelling of the Expected Change in Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Mucosal regeneration during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

The radiotherapeutic injury--a complex 'wound'.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Repopulation response of mouse oral mucosa during unconventional radiotherapy protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Consequential late effects in normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Radiation-induced changes in cellularity and proliferation in human oral mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Repair between dose fractions: a simpler method of analyzing and reporting apparently biexponential repair

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Long-term results of accelerated radiation treatment for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Accelerated hyperfractionated irradiation for advanced head and neck cancer: effect of shortening the median treatment duration by 13 days

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Review article: effects of radiation on the cell proliferation kinetics of epithelial tissues--therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer--a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

Tolerance to accelerated fractionation in the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900231-7

7 January 2021

10.1016/S0167-8140(03)00231-7

Identifiers

DOI

1 reference

9 August 2017

1 reference